Labosud Oc Biologie

What Labosud Oc Biologie does

SELAS INOVIE LABOSUD (operating as INOVIE Labosud) is a French medical biology laboratory group headquartered in Montpellier and founded in 2009 through the merger of several independent laboratories in southern France. The group operates approximately 100 proximity laboratories across the Occitanie region, organized around three major technical platforms in Béziers, Nîmes, and Montpellier and supported by roughly ten urgent technical platforms providing 24/7 emergency diagnostics. The network serves approximately 15,000 patients per day and participates in over 70% of regional medical diagnoses, employing more than 1,000 collaborators (technicians, nurses, secretaries, couriers, managers, and support staff) alongside 100 associated medical biologists who are physicians and pharmacists.

The core product is regulated medical biology diagnostic testing, delivered through physical walk-in laboratory sites and supplemented by digital result portals: monlabo.mesanalyses.fr for patients (integrated with France's national Mon Espace Santé platform) and labosud.mesresultats.fr for healthcare professionals. COVID-19 testing was added as an adjunct service, and a sample-collection manual standardizes pre-analytical handling. The technology stack is centered on ultra-performance laboratory analyzers across the major and urgent technical platforms, with web-based patient and prescriber interfaces for result delivery.

The revenue model is usage-based and reimbursed under the French social security and complementary health insurance framework at regulated NABM pricing. Customers are segmented horizontally into individual patients (direct walk-in) and the healthcare professionals who prescribe tests and consume results. The go-to-market motion is direct-to-consumer through physical laboratory proximity, with corporate marketing (inovie.fr, INOVIE Group LinkedIn, online laboratory locator) supporting patient acquisition. The legal entity is a Société d'Exercice Libéral par Actions Simplifiée (SELAS), with capital social of €113,904.87, operating as a subsidiary within the broader INOVIE Group under President Yoann Ehrhard.

Name

Labosud Oc Biologie

Legal name

SELAS INOVIE LABOSUD

Website

https://labosud-ocbiologie.fr

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

251–500 employees

Short description

INOVIE Labosud (SELAS) operates ~100 proximity medical biology laboratories across southern France, organized around 3 major technical platforms in Béziers, Nîmes, and Montpellier, serving ~15,000 patients daily under French social security reimbursement and participating in over 70% of regional diagnoses.

Ownership category

akta.pro rank

Product category

Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Central Laboratory Services (Core Lab Operations) (HLAGAEAA)

akta.pro secondary industry

Laboratory Quality Systems, Accreditation & Proficiency Testing Programs (HLAJAIAM)

Keywords

• Medical biology diagnostics
• Clinical laboratory services
• Diagnostic testing network
• Proximity healthcare laboratories
• Medical analysis services

Headquarters

HQ city

Montpellier

HQ country

France

HQ region

Europe

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Medical Biology Diagnostic Services: Laboratory diagnostic testing services for patients, billed through the French social security and health insurance system. Services include routine analyses, specialized tests, and emergency diagnostics performed across the network of 100 laboratories and technical platforms.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

INOVIE Labosud operates a multi-site network of approximately 100 medical biology laboratories across Southern France providing routine and specialized diagnostic testing, COVID-19 screening, and 24/7 emergency laboratory services. The network is supported by 3 major technical platforms in Béziers, Nîmes, and Montpellier plus roughly 10 urgent technical platforms, and serves around 15,000 patients daily. Patients access results through dedicated online portals and the national Mon Espace Santé platform, while healthcare professionals use a separate results portal.

Product overview

INOVIE Labosud operates as a multi-site medical biology laboratory network (SELAS INOVIE LABOSUD) founded in 2009 by independent medical biologists. The company comprises approximately 100 proximity laboratories organized around 3 major technical platforms in Béziers, Nîmes, and Montpellier, supported by about 10 emergency technical platforms. Services include medical biology diagnostics serving over 70% of regional medical diagnoses, COVID-19 testing, and 24/7 emergency care. Patient-facing offerings include the Mon Labo online results portal integrated with Mon Espace Santé national health platform, along with dedicated portals for healthcare professionals. The network employs over 1,000 collaborators and 100 associated medical biologists, serving approximately 15,000 patients daily.

Differentiator

Problem solved

Functional benefit

Products and services

• INOVIE Labosud Medical Biology Laboratory Services Multi-site medical biology diagnostic testing service delivered through approximately 100 proximity laboratories across Southern France, organized around 3 major technical platforms in Béziers, Nîmes, and Montpellier, serving about 15,000 patients daily with 24/7 emergency coverage.
• COVID-19 Testing Services

Quantifiable outcome

• Over 70% of regional medical diagnoses
• +2 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Lifebrain: European medical biology laboratory network with multi-site operations and central lab model. Comparable on network structure, test menu breadth, and physician-customer focus across European healthcare systems.
• Biogroup: One of France's largest multi-site medical biology laboratory networks. Directly comparable multi-site regional model serving patients and physicians with central technical platforms and proximity labs; same regulated French reimbursement framework.
• Synlab France: Major European medical diagnostics group with a significant French multi-site laboratory footprint (including former Laborizon). Closely comparable business model — proximity labs feeding central technical platforms under French social security reimbursement.
• Dynabio: French multi-site medical biology laboratory network. Comparable regional grouping of independent biologists with central technical platforms operating under the same COFRAC framework.

Broad incumbents

• Cerba Healthcare: French reference/central laboratory serving hospitals and private labs with specialized testing. Comparable on technical platform operations and clinical diagnostics, but with a national reference-lab orientation rather than proximity-patient focus.
• Unilabs France: Pan-European diagnostics group with French operations offering clinical lab, imaging, and specialty testing. Overlaps with Labosud's core routine/specialty diagnostics but operates as a broader portfolio across multiple European countries.
• Eurofins Genoma (France): French arm of global life-sciences group Eurofins offering medical diagnostics and specialty testing. Comparable central-laboratory model and clinical diagnostics menu, but with a much broader international portfolio.

Regional players

• Laborizon (now part of Synlab): Former French regional multi-site medical biology network (acquired by Synlab). Provides a useful historical peer for INOVIE Labosud's regional multi-site model in France prior to consolidation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/labosud-oc-biologie

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Labosud Oc Biologie